Code Biotherapeutics, Inc. — Form D/A
Code Biotherapeutics, Inc. of HATFIELD, PA, a company, filed a Form D amendment with the SEC on 2021-04-21. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-04-21
- Form: D/A
- Accession: 0001192482-21-000345
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 6
- Date of first sale: 2021-03-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-392951
Issuer
- Name: Code Biotherapeutics, Inc.
- CIK: 0001852269
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 2801 STERLING DRIVE, HATFIELD, PA, 19440
- Phone: 215-996-3006
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Dmitry C Kuzmin | Director | Hatfield, PA |
| Robert C Lin | Director | Hatfield, PA |
| Edward C Mathers | Director | Hatfield, PA |
| Victor C Stone | Director | Hatfield, PA |
| Edward Mathers | Director | South San Francisco, CA |
| Russ Fein | Director | Louisville, CO |
| Russ Fein | Executive Officer | Louisville, CO |
| Dmitry Kuzmin | Director | St Peter Port, Y7 |
| Joseph Truitt | Director | Hatfield, PA |
| Victor Stone | Director | Hatfield, PA |
| Brian McVeigh | Director | Hatfield, PA |
| Brian McVeigh | Executive Officer | Hatfield, PA |
| Kathy Rouan | Director | Hatfield, PA |
| Robert C Getts | Executive Officer | Hatfield, PA |
| Robert Lin | Director | Hatfield, PA |
| Lauren C Kaskiel | Executive Officer | Hatfield, PA |
| Erin C Brubaker | Executive Officer | Hatfield, PA |
Other filings by this issuer (2)
More